The Hospital Universitario Insular de Gran Canaria is a teaching hospital of general scope in Gran Canaria. Located in the city of Las Palmas de Gran Canaria, it was founded 13 February 1971 and consists in Februar 2021 of 503 beds. The first patient was hospitalized 20 September 1971.

During the past decade, Hospital Universitario Insular de Gran Canaria conducted 83 clinical trials. In the 10-year time frame, 83 clinical trials started and 31 clinical trials were completed, i.e. on average, 37.3% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 20 clinical trials were completed. i.e. 46.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Insular de Gran Canaria" #1 sponsor was "Hoffmann-La Roche" with 13 trials, followed by "Fundación GECP" with 11 trials sponsored, "Spanish Lung Cancer Group" with 8 trials sponsored, "Grupo Español Multidisciplinar de Melanoma" with 6 trials sponsored and "Spanish Breast Cancer Research Group" with 6 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Insular de Gran Canaria" #1 collaborator was "Bristol-Myers Squibb" with 6 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Insular de Gran Canaria" are "Carcinoma, Non-Small-Cell Lung" (9 trials), "Breast Cancer" (8 trials), "Lung Cancer" (7 trials), "Non Small Cell Lung Cancer" (5 trials) and "Cancer" (4 trials). Many other conditions were trialed in "Hospital Universitario Insular de Gran Canaria" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Insular de Gran Canaria" are "Drug" (80 trials), "Device" (6 trials), "Procedure" (4 trials), "Other" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (12 trials), "Atezolizumab" (11 trials), "Paclitaxel" (9 trials), "Docetaxel" (7 trials) and "Nivolumab" (7 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Insular de Gran Canaria" are 101 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario Insular de Gran Canaria". undefined are not yet recruiting, 26 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Hospital Universitario Insular de Gran Canaria, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Insular de Gran Canaria, 5 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 7 trials that are defined as “Not Applicable".